Randomized Phase 2 Study Comparing Pathological Responses of Resected Colorectal Cancer Metastases after Bevacizumab with mFOLFOX6 or FOLFIRI (BEV-ONCO Trial). - Baldin P; Carrasco J; Beniuga G; Jouret-Mourin A; Demolin G; Roland S; D'Hondt L; Vergauwe P; Van Daele D; Mailleux M; Sinapi I; De Cuyper A; et al. (Cancers, 2022)